Effects of Mesenchymal Stem Cell Transplantation on Cerebrospinal Fluid Biomarkers in Progressive Multiple Sclerosis.

Stem Cells Transl Med · 2022 · PMC8895488 · PMID 35641166

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, this trend of reduction of CXCL13 in the MSC-IT group did not reach statistical significance compared with the change (increase) observed in the placebo group.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.